ONC / BeOne Medicines AG - Depositary Receipt (Common Stock) - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Insider Trading Chart

Insider Roster and Profitability Metrics

This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings. Additionally, when possible we provide the historical trade performance for the insider. The historical trade performance is a weighted average of the performance of actual open-market purchase transactions made by the insider. For more information on how this is calculated, watch this YouTube webinar.

See our leaderboard of most profitable insider traders.

Report errors via our new Insider Auditing Tool

Track Records of Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ONC / BeOne Medicines AG - Depositary Receipt (Common Stock). This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical .

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2021-09-10	AMGEN INC	165,529	302.0615	165,529	302.0615	49,999,938	7	403.14	16,731,423	33.46
2018-08-02	BAKER BROS. ADVISORS LP	582,200	108.0000	582,200	108.0000	62,877,600
2018-08-02	BAKER BROS. ADVISORS LP	5,231,900	108.0000	5,231,900	108.0000	565,045,200
2018-01-18	BAKER BROS. ADVISORS LP	335,050	101.0000	335,050	101.0000	33,840,050
2018-01-18	BAKER BROS. ADVISORS LP	1,645,148	101.0000	1,645,148	101.0000	166,159,948
2017-08-11	BAKER BROS. ADVISORS LP	17,777	71.0000	17,777	71.0000	1,262,167
2017-08-11	BAKER BROS. ADVISORS LP	158,279	71.0000	158,279	71.0000	11,237,809
2016-11-23	Malley Thomas	30,000	32.0000	30,000	32.0000	960,000
2016-11-18	BAKER BROS. ADVISORS LP	165,824	32.0000	165,824	32.0000	5,306,368

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Track Records of Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ONC / BeOne Medicines AG - Depositary Receipt (Common Stock). A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical .

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
2025-09-02	Ball Titus B.	122	326.7600	122	326.7600	39,865	2	318.7300	-979	-2.46
2025-08-01	Rosenberg Aaron	1,190	290.4700	1,190	290.4700	345,659
2025-07-30	Lee Chan Henry	920	304.6008	920	304.6008	280,233
2025-06-23	Wang Lai	1,028	260.0000	1,028	260.0000	267,280
2025-06-23	Wu Xiaobin	1,363	260.0000	1,363	260.0000	354,380
2025-06-23	OYLER JOHN	3,074	261.5712	3,074	261.5712	804,070
2025-06-23	OYLER JOHN	100	262.9000	100	262.9000	26,290
2025-06-17	OYLER JOHN	1,460	256.4885	1,460	256.4885	374,473
2025-06-17	Wu Xiaobin	630	250.8686	630	250.8686	158,047

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.